Ultragenyx Pharmaceutical (RARE) EBT Margin Growth (3y) (2019 - 2026)
Ultragenyx Pharmaceutical (RARE) EBT Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,237.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 441.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -408.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 363.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Ultragenyx Pharmaceutical | 2.72 Bn | 2.31 Bn | 106.00 Mn | 2,738.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,738.00 |
| Dec 31, 2025 | 8,961.00 |
| Sep 30, 2025 | 15,104.00 |
| Jun 30, 2025 | 10,822.00 |
| Mar 31, 2025 | 8,194.00 |
| Dec 31, 2024 | -47,742.00 |
| Sep 30, 2024 | -631.00 |
| Jun 30, 2024 | 5,131.00 |
| Mar 31, 2024 | -1,982.00 |
| Dec 31, 2023 | -28,102.00 |
| Sep 30, 2023 | -7,804.00 |
| Jun 30, 2023 | -18,859.00 |
| Mar 31, 2023 | 16,401.00 |
| Dec 31, 2022 | -101,496.00 |
| Sep 30, 2022 | 17,353.00 |
| Jun 30, 2022 | 23,310.00 |
| Mar 31, 2022 | 34,140.00 |
| Dec 31, 2021 | 93,851.00 |
| Sep 30, 2021 | 65,096.00 |
| Jun 30, 2021 | 27,110.00 |